Fri, 26th Oct 2018 10:56
LONDON (Alliance News) - BioPharma Credit PLC's C shares were temporarily suspended from trading on the specialist fund segment of the London Stock Exchange pending an announcement by the firm.
Shares in the life sciences debt investment trust were flat at USD1.06 each on Friday.
(Alliance News) - BioPharma Credit PLC on Thursday announced a major investment in a Swiss cancer treatment specialist.
(Alliance News) - BioPharma Credit PLC on Wednesday announced it entered into a secured loan agreement with Tarsus Pharmaceuticals Inc.
(Alliance News) - BioPharma Credit PLC on Wednesday reported an uptick in net asset value as it expects its investment pipeline to grow this year.
Biopharma Cred. (BPCR)